Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043281
Filing Date
2025-05-14
Accepted
2025-05-14 16:02:13
Documents
58
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0240351-10q_adial.htm   iXBRL 10-Q 426234
2 CERTIFICATION ea024035101ex31-1_adial.htm EX-31.1 8411
3 CERTIFICATION ea024035101ex31-2_adial.htm EX-31.2 8404
4 CERTIFICATION ea024035101ex32-1_adial.htm EX-32.1 4033
5 CERTIFICATION ea024035101ex32-2_adial.htm EX-32.2 3936
  Complete submission text file 0001213900-25-043281.txt   3574545

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20250331.xsd EX-101.SCH 33866
7 XBRL CALCULATION FILE adil-20250331_cal.xml EX-101.CAL 29033
8 XBRL DEFINITION FILE adil-20250331_def.xml EX-101.DEF 167867
9 XBRL LABEL FILE adil-20250331_lab.xml EX-101.LAB 315285
10 XBRL PRESENTATION FILE adil-20250331_pre.xml EX-101.PRE 182082
60 EXTRACTED XBRL INSTANCE DOCUMENT ea0240351-10q_adial_htm.xml XML 307239
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 25945156
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)